Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
4 studies found for:    "Tetrahydrobiopterin deficiency"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
"Tetrahydrobiopterin deficiency" (4 records)
Need help? See Downloading Content for Analysis
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency
Conditions: Tetrahydrobiopterin Deficiencies;   Hyperphenylalaninemia, Non-Phenylketonuric
Intervention: Drug: Phenoptin
2 Recruiting Observational Study on the Long Term Safety of Kuvan® Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency
Condition: Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency
Intervention:
3 Completed A Phase 2, Pharmacokinetic Study of the Effects of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction
Condition: Endothelial Dysfunction
Intervention: Drug: 6R-BH4 (sapropterin dihydrochloride)
4 Completed A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension
Condition: Hypertension
Intervention: Drug: 6R-BH4 (sapropterin dihydrochloride)
To Top

† Indicates status has not been verified in more than two years